Cargando…

Spontaneous resolution of advanced basal cell carcinoma after short-pulse treatment with hedgehog pathway inhibitor

Detalles Bibliográficos
Autores principales:	Jacobsen, Audrey A., Strasswimmer, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011173/ https://www.ncbi.nlm.nih.gov/pubmed/27626056 http://dx.doi.org/10.1016/j.jdcr.2016.06.010

Ejemplares similares

Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – role of smoothened inhibitors
por: Fecher, Leslie A, et al.
Publicado: (2015)

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor?
por: Hou, Xiaoyi, et al.
Publicado: (2020)

Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting
por: De Giorgi, Vincenzo, et al.
Publicado: (2021)

Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response
por: Gambini, Donatella, et al.
Publicado: (2022)

Optimizing the pharmacokinetics of sonidegib in small bowel syndrome and advanced basal cell carcinoma: Our solution
por: Grubbs, Hailey, et al.
Publicado: (2023)

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
por: Lacouture, Mario E., et al.
Publicado: (2016)

Hedgehog Pathway Inhibitors: Clinical Implications and Resistance in the Treatment of Basal Cell Carcinoma
por: Habashy, Suzanne, et al.
Publicado: (2021)

Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients
por: DeTemple, Viola K., et al.
Publicado: (2022)

Qualitative Patient Interviews to Characterize the Human Burden of Advanced Basal Cell Carcinoma Following Hedgehog Pathway Inhibitor Treatment
por: Konidaris, Gerasimos, et al.
Publicado: (2023)

Update on Hedgehog Pathway Inhibitor Therapy for Patients with Basal Cell Naevus Syndrome or High-frequency Basal Cell Carcinoma
por: VERKOUTEREN, Babette J. A., et al.
Publicado: (2022)

Hedgehog Pathway Inhibitors and Their Utility in Basal Cell Carcinoma: A Comprehensive Review of Current Evidence
por: Tay, Evelyn Yu-Xin, et al.
Publicado: (2018)

Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma
por: Doan, Hung Q., et al.
Publicado: (2021)

Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib
por: Hehlgans, Stephanie, et al.
Publicado: (2018)

Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma
por: Lear, John T., et al.
Publicado: (2021)

Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma
por: Cucchi, Danilo, et al.
Publicado: (2012)

The Role of Actin in Muscle Spasms in a Case Series of Patients with Advanced Basal Cell Carcinoma Treated with a Hedgehog Pathway Inhibitor
por: Teh, Natalie, et al.
Publicado: (2020)

Treatment of periocular advanced basal cell carcinoma with Hedgehog pathway inhibitors: A single-center study and a new dedicated therapeutic protocol
por: De Giorgi, Vincenzo, et al.
Publicado: (2021)

Evaluation of the ‘Hedgehog’ signaling pathways in squamous and basal cell carcinomas of the eyelids and conjunctiva
por: CELEBI, ALI RIZA CENK, et al.
Publicado: (2016)

Activation of the Hedgehog and Wnt/β-Catenin Signaling Pathways in Basal Cell Carcinoma
por: Takada, Tomoaki
Publicado: (2021)

Expression of Hedgehog Signaling Pathway Proteins in Basal Cell Carcinoma: Clinicopathologic Study
por: Deng, Li-Jia, et al.
Publicado: (2022)

Systemic hedgehog inhibitors to treat locally advanced basal cell carcinomas of the head–neck region: A retrospective study
por: Villani, Alessia, et al.
Publicado: (2021)

Rapid response to cemiplimab for advanced cutaneous squamous cell carcinoma
por: Zargham, Hanieh, et al.
Publicado: (2022)

An old friend with new skills: Imiquimod as novel inhibitor of Hedgehog signaling in basal cell carcinoma
por: Gruber, Wolfgang, et al.
Publicado: (2014)

Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein
por: Vogt, Annika, et al.
Publicado: (2004)

Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM database
por: Bassompierre, A., et al.
Publicado: (2021)

Arsenic Trioxide, Itraconazole, All-Trans Retinoic Acid and Nicotinamide: A Proof of Concept for Combined Treatments with Hedgehog Inhibitors in Advanced Basal Cell Carcinoma
por: Cosio, Terenzio, et al.
Publicado: (2020)

Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
por: Villani, Alessia, et al.
Publicado: (2020)

Non-canonical hedgehog pathway activation by MKL1/SRF promotes drug-resistance in basal cell carcinomas
por: Whitson, Ramon J., et al.
Publicado: (2018)

Downregulation of the Sonic Hedgehog/Gli pathway transcriptional target Neogenin-1 is associated with basal cell carcinoma aggressiveness
por: Casas, Bárbara S., et al.
Publicado: (2017)

Novel Approaches in Non-Melanoma Skin Cancers—A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC)
por: Chmiel, Paulina, et al.
Publicado: (2022)

Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma
por: Kim, Hye Sung, et al.
Publicado: (2019)

Modulation of Hedgehog Signaling for the Treatment of Basal Cell Carcinoma and the Development of Preclinical Models
por: Dukes, Meghan W., et al.
Publicado: (2022)

Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?
por: Eibenschutz, Laura, et al.
Publicado: (2021)

Implication of the Hedgehog pathway in hepatocellular carcinoma
por: Della Corte, Carminia Maria, et al.
Publicado: (2017)

Clinical implications of hedgehog signaling pathway inhibitors
por: Liu, Hailan, et al.
Publicado: (2011)

Hedgehog Pathway Inhibitors against Tumor Microenvironment
por: Gampala, Silpa, et al.
Publicado: (2021)

Long-Noncoding RNA ANCR Activates the Hedgehog Signaling Pathway to Promote Basal Cell Carcinoma Progression by Binding to PTCH
por: Wu, Hongxuan, et al.
Publicado: (2022)

Analysis of residual disease in periocular basal cell carcinoma following hedgehog pathway inhibition: Follow up to the VISORB trial
por: Unsworth, Shelby P., et al.
Publicado: (2022)

Real-World Treatment Patterns and Outcomes Among Patients with Basal Cell Carcinoma Following First-Line Hedgehog Inhibitor Discontinuation
por: Cowey, Lance, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0n19s5aolf50fcp57n51nrechv